 | | PRD_000943 | | Name: | Protein phyllopod | | Formula: | C74 H138 N24 O16 S | | Definition date: | 2013-08-14 | | Last modified: | 2013-08-14 |
|
 | | PRD_001070 | | Name: | bacitracin A2 | | Formula: | C66 H106 N17 O16 S | | Definition date: | 2013-08-14 | | Last modified: | 2013-08-14 |
|
 | | PRD_000970 | | Name: | Synthetic peptide LR | | Formula: | C43 H72 N13 O13 S | | Definition date: | 2013-07-24 | | Last modified: | 2013-07-24 |
|
 | | PRD_000926 | | Name: | bicyclic peptide UK18-D-Ser, uPA inhibitor | | Formula: | C78 H124 N27 O25 S3 | | Definition date: | 2013-07-17 | | Last modified: | 2013-07-17 |
|
 | | PRD_000927 | | Name: | bicyclic peptide UK18-D-Aba inhibitor of uPA | | Formula: | C79 H126 N27 O24 S3 | | Definition date: | 2013-07-17 | | Last modified: | 2013-07-17 |
|
 | | PRD_001127 | | Name: | GRAMICIDIN A | | Formula: | C103 H140 N20 O17 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2013-07-10 | | Last modified: | 2013-07-10 |
|
 | | PRD_000813 | | Name: | Glyco-Arylomycin | | Formula: | C53 H78 N6 O16 | | Description: | BAL4850C IS A VARIANT OF THE LIPOGLYCO ARYLOMYCIN HERE BAL4850C IS REPRESENTED BY GROUPING TOGETHER THE SEQUENCE, THE LIPID (O2U) AND RHAMNOSE. | | Definition date: | 2012-12-12 | | Last modified: | 2013-07-02 |
|
 | | PRD_001128 | | Name: | GRAMICIDIN C | | Formula: | C101 H139 N19 O18 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2013-07-01 | | Last modified: | 2013-07-01 |
|
 | | PRD_001129 | | Name: | Microcin C7 analog | | Formula: | C28 H51 N12 O11 S | | Definition date: | 2013-07-01 | | Last modified: | 2013-07-01 |
|
 | | PRD_001126 | | Name: | Microcin C7 ANALOG | | Formula: | C28 H51 N12 O11 Se | | Definition date: | 2013-06-26 | | Last modified: | 2013-06-26 |
|
 | | PRD_001122 | | Name: | CYCLOSPORIN D | | Formula: | C64 H115 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | | Definition date: | 2013-06-20 | | Last modified: | 2013-06-20 |
|
 | | PRD_001123 | | Name: | CYCLOSPORIN C | | Formula: | C64 H114 N10 O14 | | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). THIS IS A CYCLOSPORIN C VARIANT THAT DIFFERS AT 1, 3, AND 9 POSITIONS. | | Definition date: | 2013-06-20 | | Last modified: | 2013-06-20 |
|
 | | PRD_001102 | | Name: | M48U12 | | Formula: | C133 H217 N39 O31 S6 | | Definition date: | 2013-06-19 | | Last modified: | 2013-06-19 |
|
 | | PRD_001108 | | Name: | CYCLOSPORIN A | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 8 TO BE 4,N-DIMETHYLNORLEUCINE. | | Definition date: | 2013-06-19 | | Last modified: | 2013-06-19 |
|
 | | PRD_000925 | | Name: | Caspase inhibitor | | Formula: | C42 H58 N6 O12 | | Definition date: | 2013-06-12 | | Last modified: | 2013-06-12 |
|
 | | PRD_001094 | | Name: | CD4-MIMETIC MINIPROTEIN M48U1 | | Formula: | C133 H216 N38 O32 S6 | | Definition date: | 2013-06-12 | | Last modified: | 2013-06-12 |
|
 | | PRD_001099 | | Name: | CD4-MIMETIC MINIPROTEIN M48U7 | | Formula: | C131 H214 N38 O33 S6 | | Definition date: | 2013-06-12 | | Last modified: | 2013-06-12 |
|
 | | PRD_000995 | | Name: | D-peptide inhibitor DPMI-delta | | Formula: | C73 H106 F3 N18 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-10 |
|
 | | PRD_000967 | | Name: | macrocyclic peptidomimetic | | Formula: | C56 H84 N16 O9 | | Definition date: | 2013-03-06 | | Last modified: | 2013-06-07 |
|
 | | PRD_000898 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S,16S,19S,22S)-16-(3-AMINO-3-OXOPROPYL)-2,13-DIBENZYL-12,22-DIHYDROXY-3,5,17-TRIMETHYL-8-(2-METHYLPROPYL)-4,7,10,15,18,21-HEXAOXO-19-(PROPAN-2-YL)-3,6,9,14,17,20-HEXAAZATRICOSAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE (NON-PREFERRED NAME) | | Formula: | C50 H74 N8 O12 | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000899 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C53 H67 N7 O11 S | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000910 | | Name: | B4Z inhibitor | | Formula: | C24 H44 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000911 | | Name: | C4Z inhibitor | | Formula: | C27 H42 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000912 | | Name: | C6Z inhibitor | | Formula: | C34 H54 N8 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000921 | | Name: | Noxa BH3 peptide (cysteine-mediated cross-linked) | | Formula: | C106 H179 N33 O25 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
